|mrk stock msn||0.16||0.6||9335||14|
Merck & Co. Inc. stock rises Friday, still underperforms market Jan. 14, 2022 at 5:10 p.m. ETby MarketWatch Automation Merck & Co. Inc. stock outperforms market on strong trading dayWhat are Mrkus stock prices after hours?
MRKUS After Hours Last Updated: Jan 14, 2022 7:57 p.m. ESTDelayed quote $81.38 0.020.00% After Hours Volume:1.14M Close Chg Chg % $81.38 0.06 0.07% Toggle Chart Options Advanced ChartingWhat day does Merck stock outperform the market?
Jan. 10, 2022 at 10:39 a.m. ET Merck & Co. Inc. stock outperforms market on strong trading day Jan. 7, 2022 at 5:10 p.m. ETby MarketWatch Automation Canada Decision on Oral Covid-19 Drugs Likely Weeks Away Jan. 7, 2022 at 12:09 p.m. ET BreakingIs Merck's molnupiravir FDA-approved?
Merck's (MRK) oral antiviral molnupiravir secures the FDA-authorized emergency use tag in treating mild-to-moderate COVID-19 in adults for whom other FDA-approved COVID treatments are unsuitable. FDA approves Pfizer's (PFE) and Merck's (MRK) oral COVID antiviral pills and AstraZeneca's (AZN) asthma medicine, Tezspire (tezepelumab).